QUOTE AND NEWS
StreetInsider.com  2 hrs ago  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Pharmasset%2C+Inc.+%28VRUS%29+Posts+Q4+Loss+of+%240.49%2C+Wider+than+Expectations/5324298.html for the full story.
PR Newswire  2 hrs ago  Comment 
PRINCETON, N.J., Feb. 9 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial
StreetInsider.com  Feb 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Pharmasset++%28VRUS%29+Files+%24150M+Mixed+Shelf/5315979.html for the full story.
PR Newswire  Jan 29  Comment 
PRINCETON, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announced today the underwriter of its recent stock offering has exercised its option to purchase an additional 230,400 shares of common stock. The net proceeds to
StreetInsider.com  Jan 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Pharmasset+%28VRUS%29+Prices+1.6M+Common+Offering+at+%2418.75Share/5283134.html for the full story.
StreetInsider.com  Jan 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Pharmasset+%28VRUS%29+Files+%2430M+Common+Shelf/5281360.html for the full story.
PR Newswire  Jan 27  Comment 
PRINCETON, N.J., Jan. 27 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announced today that it has commenced an underwritten public offering, subject to market and other conditions, of $30,000,000 of its common stock pursuant to effective
PR Newswire  Jan 21  Comment 
PRINCETON, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) today announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in
PR Newswire  Jan 8  Comment 
PRINCETON, N.J., Jan. 8 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the 28th Annual JPMorgan Healthcare Conference being held from January 11 to 14, 2010 at the Westin St Francis in San
PR Newswire  Nov 25  Comment 
PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, reported financial results for



Thank you for your suggestion


 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki